USANA Health Sciences Inc (USNA)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.41 | 1.26 | 1.23 | 1.26 | 1.27 | 1.28 | 1.29 | 1.33 | 1.37 | 1.35 | 1.38 | 1.47 | 1.46 | 1.45 | 1.41 | 1.45 | 1.45 | 1.48 | 1.47 | 1.49 |
The solvency ratios for USANA Health Sciences Inc paint a picture of financial stability and strength over the analyzed periods.
1. Debt-to-assets ratio: The company consistently maintained a debt-to-assets ratio of 0.00 throughout the periods, indicating that it had no debt relative to its total assets. This implies a low risk of insolvency due to debt obligations.
2. Debt-to-capital ratio: Similar to the debt-to-assets ratio, the debt-to-capital ratio remained at 0.00 across all periods. This implies that the company's capital structure was not reliant on debt financing, further enhancing its solvency position.
3. Debt-to-equity ratio: The debt-to-equity ratio also remained at 0.00 in all periods, indicating that the company's equity financing completely outweighed its debt. This suggests a strong financial position with minimal financial risk related to debt.
4. Financial leverage ratio: The financial leverage ratio fluctuated slightly but generally decreased over the periods, reaching a low of 1.23 by June 30, 2024. A decreasing trend in this ratio indicates that the company relied less on debt to finance its operations and investments, which is a positive sign for solvency.
Overall, USANA Health Sciences Inc demonstrated exceptional solvency throughout the analyzed periods with minimal debt levels relative to its assets, capital, and equity. The decreasing trend in the financial leverage ratio further reinforces the company's financial stability and ability to meet its financial obligations.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 244.89 | 294.14 | 317.30 | 358.11 | 392.04 | 663.04 | 735.33 | 544.64 | 566.73 | 660.92 | 821.68 | 1,900.92 | 2,994.72 | — | 681.87 | 373.96 | 351.98 | 104.37 | 571.33 | 2,045.87 |
The interest coverage ratio measures a company's ability to meet its interest payments on outstanding debt. A higher ratio indicates a company is more capable of covering its interest obligations.
USANA Health Sciences Inc's interest coverage ratio fluctuated over the period from March 31, 2020, to December 31, 2024. Starting at a very high level of 2,045.87 in March 2020, the ratio dropped significantly to 104.37 in September 2020, indicating a potential strain on the company's ability to cover interest payments. However, the ratio improved in the following periods, reaching levels above 500 in December 2020 and March 2021.
The interest coverage ratio continued to vary over the next years, with fluctuations between 300 and almost 3,000 by December 2021. This range suggests that the company's ability to cover interest expenses improved significantly and then fluctuated over the period. The ratio decreased to around 300 in March 2022 and went up to approximately 820 in June 2022. It dropped again by September 2022 but remained above 600.
From December 2022 onwards, the interest coverage ratio generally declined, indicating a potential decrease in the company's ability to cover interest payments effectively. The ratio fell below 400 by the end of March 2024, suggesting a decrease in the company's ability to cover interest expenses during that period.
Overall, the interest coverage ratio of USANA Health Sciences Inc showed significant variability over the analyzed period, with both highs and lows reflecting changes in the company's ability to meet its interest obligations.